Increase/Decrease in Cash: The total change in cash for the company over the given period.
Biogen Inc. (BIIB) had Increase/Decrease in Cash of $223.30M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.43B |
|
$240.50M |
|
$629.30M |
|
$1.80B |
|
$2.05B |
|
$379.60M |
|
$-68.40M |
|
$311.20M |
|
$311.20M |
|
$240.50M |
|
$240.50M |
|
$240.50M |
|
$240.50M |
|
$379.60M |
|
$614.20M |
|
146.10M |
|
146.60M |
|
$1.65 |
|
$1.64 |
|
| Balance Sheet Financials | |
$7.63B |
|
$3.13B |
|
$20.41B |
|
$28.03B |
|
$5.30B |
|
$4.55B |
|
$5.76B |
|
$11.05B |
|
$16.98B |
|
$917.00M |
|
$16.98B |
|
146.50M |
|
| Cash Flow Statement Financials | |
$259.30M |
|
$-47.30M |
|
$-23.00M |
|
$2.38B |
|
$2.60B |
|
|
Increase/Decrease in Cash |
$223.30M |
$81.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
0.21 |
|
0.37 |
|
74.11% |
|
15.62% |
|
15.62% |
|
-- |
|
12.80% |
|
9.89% |
|
$222.20M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.28 |
|
1.22 |
|
73.91 |
|
1.42% |
|
26.23% |
|
0.86% |
|
1.12% |
|
$115.90 |
|
$1.52 |
|
$1.77 |
|